Single Method for the Separation and Detection of Psilocybin, Related Tryptamines, and Beta-Carbolines Found in Psychedelic Mushrooms

Importance of the Topic

The quantification of psychoactive alkaloids in psychedelic mushrooms is critical for ensuring accurate dosing, safety in clinical applications, and advancing research into their therapeutic potential. Variability in compound content across species and growth conditions demands robust analytical methods to support pharmaceutical and quality control efforts.

Objectives and Study Overview

This study aimed to develop a single, rapid chromatographic method capable of separating a panel of ten compounds—six tryptamines (including psilocybin and related analogs) and four β-carbolines—found in psychedelic mushrooms. The method leverages advanced surface chemistry to mitigate analyte interactions with metal oxide surfaces and employs an automated workflow to enhance reproducibility and efficiency.

Methodology and Instrumentation

An HPLC method was established using a Waters Arc Premier QSM-r system equipped with MaxPeak High Performance Surfaces (HPS) technology to reduce metal-oxide interaction. The Empower Sample Set Generator (SSG) automated method creation and optimization. Chromatographic separation employed an XSelect Premier HSS T3 column (2.5 μm, 4.6 × 100 mm) at 25 °C, with a 0.75 mL/min flow rate and a 9-minute gradient of 12–55% methanol (0.1% formic acid). Detection was performed by a 2998 PDA detector at 254 nm and an ACQUITY QDa mass detector in positive mode (m/z 100–400).

Results and Discussion

The optimized method achieved baseline resolution (USP >1.95) for all ten analytes within a 15-minute run, with critical separation of aeruginascin and baeocystin. Comparing MaxPeak HPS to standard stainless-steel hardware revealed up to 426% increase in peak area and 882% increase in peak height, along with reduced tailing (e.g., norharmane tailing factor decreased from 2.3 to 1.6). Replicate injections showed lower relative standard deviations for peak area and height, underscoring enhanced reproducibility.

Practical Benefits and Applications

• A single rapid method for comprehensive profiling of psilocybin-related tryptamines and β-carbolines supports clinical research and quality control.
• Use of methanol as a green solvent reduces environmental impact.
• MaxPeak HPS technology improves sensitivity, peak shape, and method robustness.
• Automated method setup via Empower SSG streamlines workflows and minimizes user error.

Future Trends and Opportunities

• Integration with high-resolution mass spectrometry for structural elucidation of new metabolites.
• Application of AI-driven optimization for faster method development.
• Expansion to related natural product matrices and broader alkaloid profiling.
• Development of miniaturized and field-deployable chromatographic platforms.

Conclusion

A 15-minute HPLC method using MaxPeak HPS surfaces and an HSS T3 column provides reliable baseline separation of key psychedelic mushroom alkaloids. The approach delivers superior sensitivity, reproducibility, and eco-friendly operation, meeting the needs of clinical, pharmaceutical, and quality control laboratories.

References

1. Lauber M, Walter TH, Gilar M, DeLano M, Boissel C, Smith K, Birdsall R, Rainville P, Belanger J, Wyndham K. Low Adsorption HPLC Columns Based on MaxPeak High Performance Surfaces (HPS). Waters White Paper. 2023;720006930.
2. Irizarry R, Winczura A, Dimassi O, Minhas A, Larice J. Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis. Cureus. 2022;14(11):e31796.
3. Smith WR, Appelbaum PS. Two Models of Legalization of Psychedelic Substances. JAMA. 2021;326(8):697–698.
4. Beug MW, Bigwood J. Psilocybin and Psilocin Levels in Twenty Species From Seven Genera of Wild Mushrooms in the Pacific Northwest, U.S.A. Journal of Ethnopharmacology. 1982;5(3):271–285.
5. Sherwood A, Halberstadt A, Klein A, McCorvy J, Kaylo K, Kargbo R, Meisenheimer P. Synthetic and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushroom: Norbaeocystin, Baeocystin, and Aeruginascin. Journal of Natural Products. 2020;83:461–467.
6. Blei F, Dorner S, Fricke J, Bladeweg F, Trottmann F, Komor A, Meyer F, Hertweck C, Hoffmeister D. Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms. Chemistry – A European Journal. 2020;26:729–734.
7. Lenz C, Wick J, Hoffmeister D. Identification of ω-N-Methyl-4-hydroxytryptamine (Norpsilocin) as a Psilocybe Natural Product. Journal of Natural Products. 2017;80:2835–2838.